Macquarie Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,527
| Closed | -$225K | – | 2533 |
|
|
2022
Q3 | $225K | Sell |
2,527
-771
| -23% | -$68.6K | ﹤0.01% | 1604 |
|
|
2022
Q2 | $105K | Hold |
3,298
| – | – | ﹤0.01% | 1867 |
|
|
2022
Q1 | $114 | Hold |
3,298
| – | – | ﹤0.01% | 1917 |
|
|
2021
Q4 | $97K | Sell |
3,298
-113
| -3% | -$3.32K | ﹤0.01% | 1948 |
|
|
2021
Q3 | $87K | Buy |
3,411
+1,949
| +133% | +$49.7K | ﹤0.01% | 2028 |
|
|
2021
Q2 | $51K | Sell |
1,462
-201
| -12% | -$7.01K | ﹤0.01% | 2158 |
|
|
2021
Q1 | $68K | Sell |
1,663
-515
| -24% | -$21.1K | ﹤0.01% | 2004 |
|
|
2020
Q4 | $94K | Sell |
2,178
-25,353
| -92% | -$1.09M | ﹤0.01% | 1891 |
|
|
2020
Q3 | $1.52M | Buy |
27,531
+1,075
| +4% | +$59.3K | ﹤0.01% | 1125 |
|
|
2020
Q2 | $1.67M | Buy |
26,456
+2,731
| +12% | +$172K | ﹤0.01% | 1063 |
|
|
2020
Q1 | $1.21M | Buy |
23,725
+22,125
| +1,383% | +$1.13M | ﹤0.01% | 1040 |
|
|
2019
Q4 | $127K | Buy |
+1,600
| New | +$127K | ﹤0.01% | 1727 |
|
|
2018
Q2 | – | Sell |
-25,737
| Closed | -$1.24M | – | 2309 |
|
|
2018
Q1 | $1.24M | Buy |
25,737
+25,437
| +8,479% | +$1.23M | ﹤0.01% | 1116 |
|
|
2017
Q4 | $12K | Buy |
+300
| New | +$12K | ﹤0.01% | 2246 |
|